pharma · Not applicable, healthy volunteers · ulcerative pyoderma gangrenosum
InflaRx
InflaRx GmbH
InflaRx clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Jena, DE
- Founded
- 2007
- Employees
- 52
- Programs
- 4
- Drugs
- 20
- Patents
- 0
InflaRx projects
4 ClinicalTrials.gov programs sponsored by InflaRx.
InflaRx has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
IFX-1-P3.4
InflaRx GmbH
ulcerative pyoderma gangrenosum
1 trial -
INF904
InflaRx GmbH
Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Moderate to Severe Hidradenitis Suppurativa (HS)
1 trial -
INF904-P1.2
InflaRx GmbH
Not applicable, healthy volunteers
1 trial -
INF904-P1.3
InflaRx GmbH
Not applicable, healthy volunteers
1 trial
Frequently asked questions
How many clinical projects does InflaRx have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.